Results 151 to 160 of about 213,913 (289)
Multi-omics analysis identifies CCNB1 as a cell cycle factor driving glioblastoma progression and its inhibition by resveratrol. [PDF]
Liu B +6 more
europepmc +1 more source
ABSTRACT Purpose We present a method for absolute quantification of deuterated metabolites in vivo at 7T. We describe acquisition protocols and an analysis pipeline compatible with 7T Terra MRIs. We apply them using a 2H/1H receive array in healthy volunteers and glioblastoma patients.
Jabrane Karkouri +12 more
wiley +1 more source
Exploring the dual role of extracellular vesicles in coagulation and immune modulation in glioblastoma. [PDF]
Wolff A +14 more
europepmc +1 more source
Abstract Despite research and outreach efforts by ecologists and environmental scientists (EES), environmental crises continue to escalate. As a diverse group of concerned EES, we perceived a lack of clear guidance to articulate individual actions to improve sustainability.
Carlos Alberto Arnillas +31 more
wiley +1 more source
Socioeconomic disparities in IDH-wildtype glioblastoma survival: interactions between age and household income in a SEER cohort. [PDF]
Wang Y, Xie K, Yang K, Luo A, Zhang L.
europepmc +1 more source
The global coffee industry, supporting 25 million smallholder farmers, is vulnerable to climate change. Diversifying the coffee species portfolio beyond Arabica and robusta is a promising intervention. Liberica coffee could provide adaptive capacity, although its climate parameters for cultivation are poorly known.
Isobel M. J. Wild +3 more
wiley +1 more source
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme. [PDF]
Angom RS +13 more
europepmc +1 more source
RNA‐binding protein RBMS1: A new target for cancer diagnosis and treatment
This schematic illustrates the diverse regulatory roles of RNA‐binding motif single‐stranded interacting protein 1 (RBMS1) across multiple human cancers. In breast cancer, RBMS1 stabilizes B4GALT1 mRNA to promote PD‐L1 glycosylation, modulating tumor immune escape and immunotherapy efficacy.
Xingda Run +7 more
wiley +1 more source
Mismatch repair deficiency reshapes glioblastoma through immune suppression rather than hypermutation. [PDF]
Li A, Sears TK, Horbinski CM.
europepmc +1 more source

